[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Pages 5477-5478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02882]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before March 25, 2019. Such 
persons may also file a written request for a hearing on the 
application on or before March 25, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
October 12, 2018, Johnson Matthey Inc., 2003 Nolte Drive, West 
Deptford, New Jersey 08066, applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances 
listed in schedule I & II.

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............       2010  I
Marihuana.............................       7360  I
Tetrahydrocannabinols.................       7370  I
Dihydromorphine.......................       9145  I
Difenoxin.............................       9168  I
Amphetamine...........................       1100  II
Methamphetamine.......................       1105  II
Lisdexamfetamine......................       1205  II
Methylphenidate.......................       1724  II
Nabilone..............................       7379  II

[[Page 5478]]

 
Cocaine...............................       9041  II
Codeine...............................       9050  II
Dihydrocodeine........................       9120  II
Oxycodone.............................       9143  II
Hydromorphone.........................       9150  II
Diphenoxylate.........................       9170  II
Ecgonine..............................       9180  II
Hydrocodone...........................       9193  II
Meperidine............................       9230  II
Methadone.............................       9250  II
Methadone intermediate................       9254  II
Morphine..............................       9300  II
Thebaine..............................       9333  II
Opium tincture........................       9630  II
Oxymorphone...........................       9652  II
Noroxymorphone........................       9668  II
Alfentanil............................       9737  II
Remifentanil..........................       9739  II
Sufentanil............................       9740  II
Tapentadol............................       9780  II
Fentanyl..............................       9801  II
------------------------------------------------------------------------

    In reference to drug codes 7360 (Marijuana), and 7370 (THC), the 
company plans to bulk manufacture these drugs as synthetic. No other 
activities for these drug codes are authorized for this registration.

    Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02882 Filed 2-20-19; 8:45 am]
 BILLING CODE 4410-09-P